CCSK
MCID: KDN007
MIFTS: 40

Kidney Clear Cell Sarcoma (CCSK)

Categories: Cancer diseases, Nephrological diseases, Rare diseases

Aliases & Classifications for Kidney Clear Cell Sarcoma

MalaCards integrated aliases for Kidney Clear Cell Sarcoma:

Name: Kidney Clear Cell Sarcoma 12 15
Clear Cell Sarcoma of Kidney 12 58 71
Childhood Kidney Clear Cell Sarcoma 12
Clear Cell Sarcoma of the Kidney 17
Renal Clear Cell Sarcoma 12
Ccsk 58

Characteristics:

Orphanet epidemiological data:

58
clear cell sarcoma of kidney
Inheritance: Not applicable; Age of onset: Adolescent,Adult,Childhood,Infancy;

Classifications:

Orphanet: 58  
Rare renal diseases


External Ids:

Disease Ontology 12 DOID:4880
NCIt 49 C4264
SNOMED-CT 67 24007003
ICD10 via Orphanet 33 C64
Orphanet 58 ORPHA457246
UMLS 71 C0334488

Summaries for Kidney Clear Cell Sarcoma

Disease Ontology : 12 A kidney sarcoma that has material basis in clear cells that are characterized as cells that look clear when viewed under a microscope.

MalaCards based summary : Kidney Clear Cell Sarcoma, also known as clear cell sarcoma of kidney, is related to clear cell sarcoma and kidney rhabdoid cancer. An important gene associated with Kidney Clear Cell Sarcoma is NUTM2B (NUT Family Member 2B), and among its related pathways/superpathways are Regulation of Wnt-mediated beta catenin signaling and target gene transcription and DNA Damage Induced 14-3-3Sigma Signaling. The drugs Vincristine and Doxorubicin have been mentioned in the context of this disorder. Affiliated tissues include kidney, lung and bone.

Wikipedia : 74 Clear cell sarcoma of the kidney (CCSK) is an extremely rare type of kidney cancer comprising 3% of all... more...

Related Diseases for Kidney Clear Cell Sarcoma

Diseases related to Kidney Clear Cell Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 77)
# Related Disease Score Top Affiliating Genes
1 clear cell sarcoma 30.8 YWHAE NUTM2E NUTM2B EWSR1 CCNB3 BCOR
2 kidney rhabdoid cancer 30.4 YWHAE NUTM2B EWSR1 CCNB3 BCOR
3 congenital mesoblastic nephroma 30.1 YWHAE VGLL2 NUTM2B CCNB3 BCOR
4 endometrial stromal sarcoma 29.7 ZC3H7B YWHAE NUTM2B EWSR1 CCNB3 BCOR
5 ewing sarcoma 29.6 TLE1 EWSR1 CD99 CCNB3 BCOR
6 kidney sarcoma 29.4 YWHAE VGLL2 TLE1 SATB2 NUTM2E NUTM2B
7 bone sarcoma 29.1 EWSR1 DUX4L8 DUX4L7 CD99 CCNB3 BCOR
8 sarcoma, synovial 28.5 TLE1 SS18L1 EWSR1 DUX4L8 DUX4L7 CD99
9 kidney cortex disease 10.3 NUTM2B CCNB3 BCOR
10 endometrial stromal nodule 10.3 ZC3H7B YWHAE
11 myxoid leiomyosarcoma 10.3 ZC3H7B YWHAE BCOR
12 spindle cell synovial sarcoma 10.3 TLE1 CCNB3
13 retroperitoneal neuroblastoma 10.3 NUTM2B CD99
14 periosteal osteogenic sarcoma 10.3 SATB2 EWSR1
15 sarcoma 10.3
16 spindle cell sarcoma 10.3
17 juxtacortical osteosarcoma 10.3 SATB2 EWSR1
18 peripheral osteosarcoma 10.2 SATB2 EWSR1
19 spindle cell rhabdomyosarcoma 10.2 VGLL2 MAML3 CCNB3
20 intracranial primitive neuroectodermal tumor 10.2 EWSR1 CD99
21 extraskeletal mesenchymal chondrosarcoma 10.2 EWSR1 CD99
22 extraosseous ewings sarcoma-primitive neuroepithelial tumor 10.2 EWSR1 CD99
23 nephroma 10.2
24 neuroblastoma 10.2
25 ewing sarcoma of bone 10.2 EWSR1 CD99
26 congenital fibrosarcoma 10.2 VGLL2 EWSR1 CCNB3
27 ossifying fibromyxoid tumor 10.2 ZC3H7B MAML3 CCNB3 BCOR
28 kidney cancer 10.2
29 extraskeletal ewing sarcoma 10.1 EWSR1 CD99
30 posttransplant acute limbic encephalitis 10.1
31 extraosseous ewing sarcoma 10.1 EWSR1 CD99
32 askin's tumor 10.1 EWSR1 CD99 CCNB3
33 mesenchymal cell neoplasm 10.1 ZC3H7B EWSR1 CCNB3 BCOR
34 olfactory nerve neoplasm 10.1 EWSR1 CD99
35 pediatric fibrosarcoma 10.1 VGLL2 EWSR1 CCNB3 BCOR
36 central nervous system mesenchymal non-meningothelial tumor 10.1 NUTM2E NUTM2B EWSR1 CD99
37 skeletal muscle cancer 10.1 VGLL2 EWSR1 CD99
38 cranial nerve malignant neoplasm 10.1 EWSR1 CD99
39 vesicoureteral reflux 1 10.0
40 fanconi anemia, complementation group a 10.0
41 thymoma, familial 10.0
42 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
43 deficiency anemia 10.0
44 familial adenomatous polyposis 10.0
45 brain cancer 10.0
46 neurilemmoma 10.0
47 thymoma 10.0
48 paraplegia 10.0
49 metanephric adenoma 10.0
50 adenoma 10.0

Graphical network of the top 20 diseases related to Kidney Clear Cell Sarcoma:



Diseases related to Kidney Clear Cell Sarcoma

Symptoms & Phenotypes for Kidney Clear Cell Sarcoma

Drugs & Therapeutics for Kidney Clear Cell Sarcoma

Drugs for Kidney Clear Cell Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 72)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
2
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
3
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
4
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
5
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
6
Lenograstim Approved, Investigational Phase 3 135968-09-1
7
Sargramostim Approved, Investigational Phase 3 83869-56-1, 123774-72-1
8
Sulfamethoxazole Approved Phase 3 723-46-6 5329
9
Trimethoprim Approved, Vet_approved Phase 3 738-70-5 5578
10
Histamine Approved, Investigational Phase 3 51-45-6 774
11
Cyproheptadine Approved Phase 3 129-03-3 2913
12 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
13 Molgramostim Investigational Phase 3 99283-10-0
14 Immunologic Factors Phase 3
15 Antibiotics, Antitubercular Phase 3
16 Anti-Infective Agents Phase 3
17 Immunosuppressive Agents Phase 3
18 Anti-Bacterial Agents Phase 3
19 Antirheumatic Agents Phase 3
20
Liposomal doxorubicin Phase 3 31703
21 Anesthetics Phase 3
22 Narcotics Phase 3
23 Cola Phase 3
24 Analgesics Phase 3
25 Analgesics, Opioid Phase 3
26 Anesthetics, General Phase 3
27 Anesthetics, Intravenous Phase 3
28 Adjuvants, Immunologic Phase 3
29 Neurotransmitter Agents Phase 3
30 Histamine Antagonists Phase 3
31 Anti-Allergic Agents Phase 3
32
Histamine Phosphate Phase 3 51-74-1 65513
33 Histamine H1 Antagonists Phase 3
34 Dermatologic Agents Phase 3
35 Gastrointestinal Agents Phase 3
36
Serotonin Investigational, Nutraceutical Phase 3 50-67-9 5202
37
Melphalan Approved Phase 2 148-82-3 460612 4053
38
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
39
Amifostine Approved, Investigational Phase 2 20537-88-6 2141
40
Docetaxel Approved, Investigational Phase 1, Phase 2 114977-28-5 148124
41
Etoposide Approved Phase 1, Phase 2 33419-42-0 36462
42
Carboplatin Approved Phase 1, Phase 2 41575-94-4 10339178 38904 498142
43
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
44
Gemcitabine Approved Phase 2 95058-81-4 60750
45
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
46
Dasatinib Approved, Investigational Phase 1, Phase 2 302962-49-8 3062316
47
Oblimersen Experimental, Investigational Phase 1, Phase 2 190977-41-4
48 topoisomerase I inhibitors Phase 2
49 Protective Agents Phase 2
50 Radiation-Protective Agents Phase 2

Interventional clinical trials:

(show all 22)
# Name Status NCT ID Phase Drugs
1 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
2 National Wilms Tumor Study-5 -- Treatment of Relapsed Patients, A National Wilms Tumor Study Group Phase III Study Completed NCT00002610 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;vincristine sulfate
3 METASTASECTOMY AND CHEMOTHERAPY FOR LUNG METASTASES FROM SOFT TISSUE SARCOMA: A RANDOMIZED PHASE III STUDY (AN INTERGROUP STUDY WITH THE SCANDINAVIAN SARCOMA GROUP) Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
4 NATIONAL WILMS TUMOR STUDY-5 -- THERAPEUTIC TRIAL AND BIOLOGY STUDY Completed NCT00002611 Phase 3 cyclophosphamide;doxorubicin hydrochloride;etoposide;vincristine sulfate
5 RANDOMISED TRIAL OF ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE DOXORUBICIN, IFOSFAMIDE AND LENOGRASTIM IN HIGH GRADE SOFT TISSUE SARCOMA Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
6 Prevention of Cancer/Treatment-Related Weight Loss in Children at High Nutritional Risk Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
7 Protocol For The Treatment Of Relapsed And Refractory Wilms Tumour And Clear Cell Sarcoma Of The Kidney (CCSK) Unknown status NCT00025103 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;melphalan;vincristine sulfate
8 Treatment of High Risk Renal Tumors: A Groupwide Phase II Study Completed NCT00335556 Phase 2 Doxorubicin Hydrochloride;Irinotecan Hydrochloride;Cyclophosphamide;Etoposide;Carboplatin;Vincristine Sulfate
9 High Dose Ifosfamide, Carboplatin and Etoposide With Amifostine Chemoprotection Completed NCT00003657 Phase 2 Amifostine;Carboplatin;Etoposide;Ifosfamide
10 A Phase I/IIA Dose-Escalating Trial of BCL-2 Antisense (G3139) Treatment for Patients With Androgen-Independent Prostate Cancer or Other Advanced Solid Tumor Malignancies Completed NCT00003103 Phase 1, Phase 2 docetaxel
11 A Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma With Sarcomatoid Features Active, not recruiting NCT01164228 Phase 2 gemcitabine hydrochloride;sunitinib malate
12 Dasatinib With Ifosfamide, Carboplatin, Etoposide: A Pediatric Phase I/II Trial Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
13 Phase I Study of Dalteparin, A Low Molecular Weight Heparin (LMWH), in Combination With Sunitinib (SU11248), an Oral, Selective Multi-targeted Tyrosine Kinase Inhibitor, as First Line Treatment, in Patients With Metastatic Renal Cell Carcinoma Completed NCT01061411 Phase 1 Dalteparin;Sunitinib Malate
14 Phase I Pharmacokinetic Trial of Thalidomide and Docetaxel: A Regimen Based on Anti-Angiogenic Therapeutic Principles Completed NCT00049296 Phase 1 docetaxel;thalidomide
15 A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Cancer in East Anglia, Trent and West Midlands Unknown status NCT00757614
16 Descriptive Study to Evaluate the Information and Psychosocial Issues on the Risk on Infertility in Cancer Patients After Receiving Treatment in a Comprehensive Cancer Center Unknown status NCT01295463
17 Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative High-Risk Renal Tumor Project: Application of Array-Based Methods and Next Generation Sequencing to Identify Candidate Molecular Targets for High-Risk Wilms Tumors Completed NCT01118078
18 Improving Palliative Care for Patients With Cancer Completed NCT00253383
19 E-MOSAIC: A Multicenter Randomized Controlled Phase III Study of Longitudinal Electronic Monitoring of Symptoms and Syndromes Associated With Advanced Cancer in Patients Receiving Anticancer Treatment in Palliative Intention Completed NCT00477919
20 Pilot Study of Pencil Beam Scanning Proton Beam Radiation Therapy in Patients With Renal Tumors Recruiting NCT03810651 Early Phase 1
21 Focal Adhesion Kinase Expression in Pediatric Renal Tumors Withdrawn NCT01642095
22 Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Study of Nab-Paclitaxel (Nanoparticle Albumin Bound-Paclitaxel) in Patients With Advanced Solid Tumors Withdrawn NCT00499291 paclitaxel albumin-stabilized nanoparticle formulation

Search NIH Clinical Center for Kidney Clear Cell Sarcoma

Genetic Tests for Kidney Clear Cell Sarcoma

Anatomical Context for Kidney Clear Cell Sarcoma

MalaCards organs/tissues related to Kidney Clear Cell Sarcoma:

40
Kidney, Lung, Bone, Brain, Liver, Prostate

Publications for Kidney Clear Cell Sarcoma

Articles related to Kidney Clear Cell Sarcoma:

(show all 46)
# Title Authors PMID Year
1
Immunophenotype-Genotype Correlations in Clear Cell Sarcoma of Kidney-An Evaluation of Diagnostic Ancillary Studies. 61
32364435 2020
2
BCOR Overexpression in Renal Malignant Solitary Fibrous Tumors: A Close Mimic of Clear Cell Sarcoma of Kidney. 61
30864973 2019
3
Expression of cyclin D1 in clear cell sarcoma of kidney. Is it useful in differentiating it from its histological mimics? 61
30736802 2019
4
Delayed Metastasis of Clear Cell Sarcoma of Kidney to Bladder After 7 Disease-Free Years. 61
29509095 2018
5
Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues. 61
28817404 2017
6
Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplication. 61
28440018 2017
7
FNAC aided diagnosis of clear cell sarcoma of kidney: Report of two cases in infants. 61
28421721 2017
8
Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. 61
28256570 2017
9
Dual tumor - Clear cell sarcoma of kidney with differentiating neuroblastoma: A rare case with review of literature. 61
28195106 2017
10
Renal Clear Cell Sarcoma - Anaplastic Variant: A Rare Entity. 61
28273978 2017
11
Concurrent occurrence of neuroblastoma and clear cell sarcoma of kidney in an infant: Is it a random event? 61
28195107 2017
12
BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities. 61
27428733 2016
13
Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney. 61
26945340 2016
14
[Clear cell sarcoma of kidney in children]. 61
26927827 2016
15
Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story. 61
27000436 2016
16
Clear cell sarcoma of the kidney: report of two cases. 61
25374799 2014
17
Clear cell sarcoma of kidney in a neonate. 61
26023506 2014
18
Malignant renal tumors in childhood: report of 54 cases treated at a single institution. 61
24279977 2014
19
Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5. 61
22658515 2013
20
Genetics of pediatric renal tumors. 61
22461142 2013
21
Clear cell sarcoma of kidney: morphoproteomic analysis reveals genomic correlates and therapeutic options. 61
22256788 2013
22
Metanephric stromal tumour: A rare pediatric benign stromal specific renal neoplasm. 61
23671366 2013
23
Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney. 61
22294382 2012
24
Clear cell sarcoma of kidney: A rare entity. 61
22557783 2011
25
Renal tumors in children aged 10-16 Years: a report from the United Kingdom Children's Cancer and Leukaemia Group. 61
21054158 2011
26
Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. 61
16919774 2006
27
Translocation (10;17)(q22;p13): a recurring translocation in clear cell sarcoma of kidney. 61
15474157 2004
28
Myoid differentiation in mesoblastic nephroma: clinicopathologic and cytogenetic findings of a rare case. 61
12149722 2002
29
Clear cell sarcoma of kidney in an adolescent and in young adults: a report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis. 61
10584698 1999
30
[Clear cell renal carcinoma outside of the usual age group]. 61
10584353 1999
31
Clear cell sarcoma kidney: clinical features and outcome. 61
10100278 1999
32
Clear cell sarcoma of kidney with tumor extension into the right atrium. 61
9788798 1998
33
Veno-occlusive disease-like hepatotoxicity in two children receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney. 61
9509511 1998
34
[Clear cell sarcoma of the kidney in a young adult]. 61
9526626 1997
35
[Cystic renal tumours in children]. 61
17974349 1997
36
Monosomy 22 in a malignant peripheral nerve sheath tumour of the kidney in childhood: a genetic link with other malignant paediatric renal neoplasms? 61
8847069 1995
37
Clear cell sarcoma of kidney in an adult. 61
8149160 1993
38
Clear cell sarcoma of kidney. Two cases in adults. 61
8453549 1993
39
Clear cell sarcoma of kidney: a clinicopathological study of eight cases from Malaysia. 61
1328018 1992
40
Clear cell sarcoma of kidney: report of the first Malaysian case. 61
1374551 1992
41
Primitive pelvic sarcoma resembling clear cell sarcoma of kidney. 61
1755102 1991
42
Expression of the 5.1 H11 antigen, a fetal muscle surface antigen, in normal and neoplastic tissue. 61
2189373 1990
43
Clear cell sarcoma of kidney (CCSK)--a clinicopathological study of 4 cases. 61
2591997 1989
44
Case 7. Clear cell sarcoma of kidney. 61
2748484 1989
45
Congenital mesoblastic nephroma: a clinicoradiologic study of 17 cases representing the pathologic spectrum of the disease. 61
3037055 1987
46
Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center. 61
6303938 1983

Variations for Kidney Clear Cell Sarcoma

Cosmic variations for Kidney Clear Cell Sarcoma:

9 (show top 50) (show all 76)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM93992510 SRC soft tissue,lung,sarcoma,NS c.205T>G p.S69A 20:37384358-37384358 3
2 COSM93451505 RAC1 soft tissue,lung,sarcoma,NS c.533C>T p.A178V 7:6402343-6402343 3
3 COSM101931022 PTPRD soft tissue,lung,sarcoma,NS c.4160C>T p.A1387V 9:8404587-8404587 3
4 COSM90842465 PTCH1 soft tissue,lung,sarcoma,NS c.2921T>G p.F974C 9:95458260-95458260 3
5 COSM87210160 PIK3CA soft tissue,lung,sarcoma,NS c.1036G>T p.V346L 3:179203766-179203766 3
6 COSM101270110 PBRM1 soft tissue,lung,sarcoma,NS c.2834G>A p.R945H 3:52589201-52589201 3
7 COSM98770048 PAK5 soft tissue,lung,sarcoma,NS c.41C>A p.P14Q 20:9644288-9644288 3
8 COSM87804075 KRAS soft tissue,lung,sarcoma,NS c.34G>T p.G12C 12:25245351-25245351 3
9 COSM87804055 KRAS soft tissue,lung,sarcoma,NS c.35G>T p.G12V 12:25245350-25245350 3
10 COSM87850803 HGF soft tissue,lung,sarcoma,NS c.1711G>T p.V571L 7:81706333-81706333 3
11 COSM95516578 H3-3A soft tissue,bone,sarcoma,NS c.103G>T p.G35W 1:226064454-226064454 3
12 COSM100583919 GPS2 soft tissue,lung,sarcoma,NS c.454C>T p.Q152* 17:7313932-7313932 3
13 COSM87494413 GNAQ soft tissue,bone,sarcoma,NS c.442C>T p.R148* 9:77815650-77815650 3
14 COSM142908710 FOXP1 soft tissue,lung,sarcoma,NS c.74A>G p.H25R 3:71198308-71198308 3
15 COSM100233796 ERCC2 soft tissue,lung,sarcoma,NS c.1831+1G>T p.? 19:45353082-45353082 3
16 COSM128908220 DICER1 soft tissue,kidney,sarcoma,NS c.5438A>G p.E1813G 14:95091292-95091292 3
17 COSM128908198 DICER1 soft tissue,kidney,sarcoma,NS c.5425G>A p.G1809R 14:95091305-95091305 3
18 COSM117948203 soft tissue,lung,sarcoma,NS c.2939C>T p.A980V 9:8404587-8404587 3
19 COSM106841030 soft tissue,lung,sarcoma,NS c.2468T>G p.F823C 9:95458260-95458260 3
20 COSM92462437 soft tissue,kidney,sarcoma,NS c.5438A>G p.E1813G 14:95091292-95091292 3
21 COSM118450453 soft tissue,lung,sarcoma,NS c.74A>G p.H25R 3:71198308-71198308 3
22 COSM134990158 soft tissue,lung,sarcoma,NS c.35G>T p.G12V 12:25245350-25245350 3
23 COSM120158796 soft tissue,lung,sarcoma,NS c.74A>G p.H25R 3:71198308-71198308 3
24 COSM143854306 soft tissue,lung,sarcoma,NS c.74A>G p.H25R 3:71198308-71198308 3
25 COSM116715747 soft tissue,lung,sarcoma,NS c.74A>G p.H25R 3:71198308-71198308 3
26 COSM103461667 soft tissue,lung,sarcoma,NS c.2468T>G p.F823C 9:95458260-95458260 3
27 COSM91788538 soft tissue,lung,sarcoma,NS c.2834G>A p.R945H 3:52589201-52589201 3
28 COSM102558626 soft tissue,lung,sarcoma,NS c.2834G>A p.R945H 3:52589201-52589201 3
29 COSM132326062 soft tissue,lung,sarcoma,NS c.4160C>T p.A1387V 9:8404587-8404587 3
30 COSM110727009 soft tissue,lung,sarcoma,NS c.2723T>G p.F908C 9:95458260-95458260 3
31 COSM134823886 soft tissue,kidney,sarcoma,NS c.2132A>G p.E711G 14:95091292-95091292 3
32 COSM134990190 soft tissue,lung,sarcoma,NS c.34G>T p.G12C 12:25245351-25245351 3
33 COSM93619977 soft tissue,lung,sarcoma,NS c.2738G>A p.R913H 3:52589201-52589201 3
34 COSM91028178 soft tissue,lung,sarcoma,NS c.2942C>T p.A981V 9:8404587-8404587 3
35 COSM91859752 soft tissue,lung,sarcoma,NS c.35G>T p.G12V 12:25245350-25245350 3
36 COSM131473358 soft tissue,kidney,sarcoma,NS c.5365-196G>A p.? 14:95091305-95091305 3
37 COSM98743623 soft tissue,lung,sarcoma,NS c.41C>A p.P14Q 20:9644288-9644288 3
38 COSM100223095 soft tissue,lung,sarcoma,NS c.1597+1G>T p.? 19:45353082-45353082 3
39 COSM134615012 soft tissue,lung,sarcoma,NS c.34G>T p.G12C 12:25245351-25245351 3
40 COSM89028226 soft tissue,lung,sarcoma,NS c.74A>G p.H25R 3:71198308-71198308 3
41 COSM134614978 soft tissue,lung,sarcoma,NS c.35G>T p.G12V 12:25245350-25245350 3
42 COSM88073526 soft tissue,lung,sarcoma,NS c.2834G>A p.R945H 3:52589201-52589201 3
43 COSM89060405 soft tissue,lung,sarcoma,NS c.74A>G p.H25R 3:71198308-71198308 3
44 COSM132607215 soft tissue,lung,sarcoma,NS c.2912C>T p.A971V 9:8404587-8404587 3
45 COSM131473389 soft tissue,kidney,sarcoma,NS c.5365-183A>G p.? 14:95091292-95091292 3
46 COSM108525670 soft tissue,lung,sarcoma,NS c.2723T>G p.F908C 9:95458260-95458260 3
47 COSM92462418 soft tissue,kidney,sarcoma,NS c.5425G>A p.G1809R 14:95091305-95091305 3
48 COSM92729038 soft tissue,lung,sarcoma,NS c.476C>T p.A159V 7:6402343-6402343 3
49 COSM119483126 soft tissue,lung,sarcoma,NS c.74A>G p.H25R 3:71198308-71198308 3
50 COSM127764502 soft tissue,kidney,sarcoma,NS c.5425G>A p.G1809R 14:95091305-95091305 3

Expression for Kidney Clear Cell Sarcoma

Search GEO for disease gene expression data for Kidney Clear Cell Sarcoma.

Pathways for Kidney Clear Cell Sarcoma

Pathways related to Kidney Clear Cell Sarcoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.7 YWHAE TLE1 TERT
2 10.23 YWHAE CCNB3

GO Terms for Kidney Clear Cell Sarcoma

Cellular components related to Kidney Clear Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nucleus GO:0005634 9.44 ZC3H7B YWHAE VGLL2 TLE1 TERT SS18L1

Biological processes related to Kidney Clear Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 beta-catenin-TCF complex assembly GO:1904837 8.96 TLE1 TERT
2 histone H2A monoubiquitination GO:0035518 8.62 PCGF1 BCOR

Sources for Kidney Clear Cell Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....